An Experimental Study of Belzutifan Impact on Catecholamine Metabolism

NCT07680205 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Pheochromocytoma and Paraganglioma (PPGL)
Pheochromocytoma Malignant
Pheochromocytoma, Metastatic
Pheochromocytoma/Paraganglioma
Pheochromocytoma

Interventions

DRUG: Belzutifan

Sponsor

Cambridge University Hospitals NHS Foundation Trust

Collaborators

[object Object]